Iridex (IRIX) FCF Margin Growth (1y) (2012 - 2026)
Iridex (IRIX) FCF Margin Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.35 Bn | 7.27 Bn | 194.00 |
| 2 | Stryker | 128.10 Bn | 124.63 Bn | 4.50 Bn | 66.00 |
| 3 | Medtronic | 118.91 Bn | 109.69 Bn | 6.41 Bn | -192.00 |
| 4 | Boston Scientific | 73.43 Bn | 72.89 Bn | 3.85 Bn | 119.00 |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn | 1,788.00 |
| 6 | Dexcom | 34.52 Bn | 32.58 Bn | 830.00 Mn | -395.00 |
| 7 | GE HealthCare Technologies | 33.94 Bn | 31.83 Bn | 2.18 Bn | 112.00 |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | -505.00 |
| 9 | Steris | 23.14 Bn | 22.66 Bn | 684.20 Mn | -473.00 |
| 10 | Iridex | 13.32 Mn | 8.64 Mn | 4.30 Mn | 373.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | -332.00 |
| Jan 3, 2026 | 1,693.00 |
| Sep 27, 2025 | 1,469.00 |
| Jun 28, 2025 | 793.00 |
| Mar 29, 2025 | 519.00 |
| Dec 28, 2024 | -138.00 |
| Sep 28, 2024 | -1,006.00 |
| Jun 29, 2024 | -167.00 |
| Mar 30, 2024 | 702.00 |
| Dec 30, 2023 | 170.00 |
| Sep 30, 2023 | 405.00 |
| Jul 1, 2023 | 1,218.00 |
| Apr 1, 2023 | 344.00 |
| Dec 31, 2022 | -4,833.00 |
| Apr 2, 2022 | -12,386.00 |
| Apr 3, 2021 | 11,535.00 |
| Sep 26, 2020 | 3,085.00 |
| Jun 27, 2020 | -2,024.00 |
| Mar 28, 2020 | 1,977.00 |
| Dec 28, 2019 | 1,945.00 |